Question
Grover clearly described the general situation, she did not demonstrate the relationshipbetween gender differences and fatality ratio on contracting a disease and taking medicine. Forinstance,
Grover clearly described the general situation, she did not demonstrate the relationshipbetween gender differences and fatality ratio on contracting a disease and taking medicine. Forinstance, Grover stated that the heart drug Digoxin increased the mortality of females anddecreased the mortality of male. Men died twice more than often women from COVID-19 (Grover,2020). Although Grover reduced the research conclusions to get the arguments she wanted, thereare no strong evidence to prove the relationship between gender differences and mortality frominfecting diseases and taking medicine. Comparing the clinical trial data in COVID-19, 14,712patients, the number of men who are older (average age: 55.0) and suffer from hypertension,diabetes, coronary artery disease, obstructive pulmonary disease, nicotine dependence and heartfailure, but have a lower prevalence of obesity, were 6387 (43%). The mortality rate for men is8.8%, and the mortality rate for women is 4.3% (Mohamad, 2020). Grover had tried to use a lot ofexamples to interpret the relationship between analyses by sex and mortality, but her argumentslacked a close logical connection. Obviously the conclusion of clinical trials cannot only beexplained for gender difference causing the difference in mortality. So, she should use accuratequotations to adjust the logical sequence of arguments to guide readers to accurate conclusions.
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started